Alterna Wealth Management, Inc Amgen Inc Transaction History

Alterna Wealth Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $7,070 - $8,361	33 Added 3.75%	914 $202,000
Q1 2023 May 26, 2023	SELL	$225.79 - $275.2 $10,837 - $13,209	-48 Reduced 5.17%	881 $212,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $21,548 - $24,302	96 Added 11.52%	929 $209,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $1.29 Million - $1.43 Million	-5,583 Reduced 87.02%	833 $203,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.14 Million - $1.34 Million	6,416 New	6,416 $1.11 Million

3,121

407M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Alterna Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Alterna Wealth Management, Inc with notifications on news.